Ovarian Cancer Plasma

All filters

Format

Format

Format
Volume / Size

Volume / Size

Volume / Size
Condition

Condition

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

10 lots match
10 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Ovarian Cancer Plasma 76170 160954 Female 61+ Caucasian Frozen 1 mL 17 — ibuprofen 400 mg acetaminophen 500 mg methocarbamol 500 mg triazolam 0.25 mg Ovarian Cancer — 2026 — — — — — — — — — 275170; 275172; 275169; 275171; 275165; 275166; 275164; 275167; 275161; 275168; 275162; 275163; 275160; 275159; 275157; 275158; 275156Plasma1.0 MLOvarian CancerOvarian CancerNo20.94NoNoNoNoNoNONoStoredIn Stock
$667
Ovarian Cancer Plasma 76171 160615 Female 46-60 Hispanic/Latino Frozen 1 mL 35 — Tylenol 500mg - 2 tabs q6 hours; Miralax 1 capful daily; Tramadol 50mg q6 hours Ovarian Cancer United States 2026 — — — — — — — — — 271745; 271742; 271747; 271746; 271741; 271738; 271735; 271733; 271732; 271743; 271739; 271736; 271734; 271744; 271740; 271731; 271737; 271728; 271725; 271730; 271726; 271723; 271720; 271729; 271724; 271719; 271727; 271722; 271716; 271721; 271717; 271718; 271715; 271714; 271713Plasma1.0 MLOvarian CancerOvarian CancerNo21.21NoNoNoNoNoNONoStoredIn Stock
$667
Ovarian Cancer Plasma 76172 160595 Female 46-60 Asian/Pacific Islander Frozen 1 mL 16 — — Ovarian Cancer United States 2026 — — — — — — — — — 271283; 271281; 271280; 271284; 271282; 271273; 271278; 271279; 271277; 271276; 271275; 271272; 271274; 271271; 271270; 271269Plasma1.0 MLOvarian CancerOvarian CancerNo22.07NoNoNoNoNoNONoStoredIn Stock
$667
Ovarian Cancer Plasma 76645 — Female 46-60 Caucasian Frozen 2 mL 1 — No medications Ovarian Cancer Ukraine 2022 — — — — — — — — — 198495Plasma2.0 MLOvarian CancerOvarian CancerNo24.05NoNoNoStoredIn Stock
$667
Ovarian Cancer Plasma 76646 — Female 61+ Caucasian Frozen 2 mL 1 — Cardiomagnyl Ovarian Cancer Ukraine 2022 — — — — — — — — — 198494Plasma2.0 MLOvarian CancerOvarian CancerNo30.55NoNoNoStoredIn Stock
$667
Ovarian Cancer Plasma 76748 — Female 46-60 Caucasian Frozen 1 mL 1 — No medications Ovarian Cancer Ukraine 2024 — — — — — — — — — 198497Plasma1.0 MLOvarian CancerOvarian CancerNo21.96NoNoNoStoredIn Stock
$667
Ovarian Cancer Plasma 76749 — Female 46-60 Caucasian Frozen 1 mL 1 — No medications Ovarian Cancer Ukraine 2024 — — — — — — — — — 198496Plasma1.0 MLOvarian CancerOvarian CancerNo21.96NoNoNoStoredIn Stock
$667
Ovarian Cancer Plasma 76640 — Female 46-60 Caucasian Frozen 1 mL 1 — No medications Ovarian Cancer Ukraine 2022 — — — — — — — — — 198429Plasma1.0 MLOvarian CancerOvarian CancerNo31.45NoNoNoStoredIn Stock
$667
Ovarian Cancer Plasma 76638 — Female 61+ Caucasian Frozen 5 mL 1 — No medications Ovarian Cancer Ukraine 2022 — — — — — — — — — 198428Plasma5.0 MLOvarian CancerOvarian CancerNo24.54NoNoNoStoredIn Stock
$667
Ovarian Cancer Plasma 76642 — Female 61+ Caucasian Frozen 1 mL 1 — No medications Ovarian Cancer Ukraine 2022 — — — — — — — — — 198432Plasma1.0 MLOvarian CancerOvarian CancerNo32.28NoNoNoStoredIn Stock
$667

Showing 1–10 of 10 lots

About Ovarian Cancer Plasma

Ovarian Cancer Plasma is sourced from consented donors with documented ovarian cancer. These samples support immunoassay and proteomics research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Ovarian Cancer research
  • Immunoassay development
  • Proteomic research
  • Metabolomic research
  • Soluble-protein studies

Product Features

  • Human plasma
  • Donor condition: Ovarian Cancer
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Donor Stratification

Cohort characteristics include diagnosis and documented clinical phenotype, medication history, comorbidities and demographics.

Protocols & Documentation

  • Plasma Isolation

    Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Ovarian Cancer Plasma with normal donor samples for comparison

Healthy Plasma

206 In Stock
Screened normal donors · Frozen · Starting at $132
View Inventory

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information